<DOC>
	<DOC>NCT00753051</DOC>
	<brief_summary>Clozapine treatment resistant schizophrenia is still prevalent.The effectiveness of augmenting clozapine : one augmenting with haloperidol and the other with electroconvulsive therapy should be determined.This study is a randomized control trial.</brief_summary>
	<brief_title>Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>1. schizophrenic patients diagnosed with schedules for clinical assessment in neuropsychiatry ( SCAN )in accordance with DSMIVTR or ICD10 2. Resistant to at least 6 weeks of clozapine treatment in therapeutic dosage 3. Voluntary to participate the research protocol expressed by signing informed consent form 1. Patient does not volunteer himself or herself 2. Patient is having epilepsy, DM, cardiac disease, autistic disorder and illiterate 3. Patient is deaf, blind , dumb to obstruct good communication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>clozapine-resistant schizophrenics</keyword>
	<keyword>haloperidol augmenting clozapine</keyword>
	<keyword>electroconvulsive therapy augmenting clozapine</keyword>
</DOC>